Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 1997

View Archived Issues

Shaman: Q3 1997 highlights

TNFR:Fc evaluated in patients with heart failure

Sankyo synthesizes azole aromatase inhibitors

ACAT inhibitors described by Sankyo in patent literature

Suntory's penems are active against MRSA

New 5-LO inhibitors from Meiji Milk

Regeneron: Q3 1997 highlights

T Cell Sciences: Q3 1997 highlights

Xoma: Q3 1997 highlights

Guilford: Q3 1997 highlights

Neurex: Q3 1997 highlights

Promising clinical results reported for Avakine

Immunomedics issued U.S. patent for imaging and treatment of infections and inflammation

LeukoSite, Warner-Lambert and Kyowa Hakko chemokine drug discovery collaboration

TK inhibitors under development at Dr. Karl Thomae

CCK/gastrin receptor ligands from James Black Foundation

Antiinflammatory CRF analogues prepared at U of California

Conformationally constrained arginal thrombin inhibitors prepared at Lusofarmaco/Guidotti

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Alendronate and etidronate prevent steroid-induced osteoporosis

Minocycline associated with marked long-term efficacy in early RA

Preclinical antiinflammatory effects demonstrated for CT-3

Novo Nordisk files for HRT product in U.S.

Cubist acquires rights to daptomycin

Atacand launched in Sweden

Second drug from Inhale/Baxter collaboration enters clinical testing

New formulation of amiodarone shows favorable hemodynamic effects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...